Key Takeaways
- Sector: Healthcare Healthtech & Medtech.
- Geography: Vietnam.
Analysis
Vietnamese asset manager VinaCapital has announced the sale of its stake in Tam Tri Medical, a prominent private hospital chain in Vietnam, to a dedicated healthcare private equity firm operating in South and Southeast Asia. The transaction marks a significant divestment for VinaCapital's Vietnam Opportunity Fund (VOF), which had been a major shareholder in Tam Tri Medical.
VinaCapital initially invested $25 million in Tam Tri Medical in 2018, when the healthcare group operated four hospitals with approximately 400 beds. In 2022, VOF increased its investment by an additional $21 million, raising its ownership stake to 49%. During VinaCapital's holding period, Tam Tri Medical expanded its network by acquiring three additional hospitals and developing a flagship greenfield hospital.
Under VinaCapital's stewardship, Tam Tri Medical has grown to serve over one million patient visits and 20,000 surgical cases annually. The company's expansion reflects the increasing demand for private healthcare services in Vietnam, driven by a growing middle class and the need for high-quality medical care.
The sale of Tam Tri Medical to a leading healthcare-focused private equity firm underscores the attractiveness of Vietnam's healthcare sector to international investors. The acquiring firm is recognized for its expertise in the healthcare industry across South and Southeast Asia, suggesting a strategic alignment with Tam Tri Medical's growth objectives.
Khanh Vu, Lead Portfolio Manager of VOF, commented on the transaction: "We sold our stake at a premium to one of the region’s foremost healthcare investors who understand the market and its enormous potential." He added that the divestment allows VinaCapital to reallocate capital to other promising investment opportunities within Vietnam's dynamic private sector.
This exit follows a trend of increased merger and acquisition activity in Vietnam's healthcare industry, as both domestic and foreign investors seek to capitalize on the sector's growth potential. The successful divestment of Tam Tri Medical highlights VinaCapital's ability to identify and nurture high-performing assets within the country's evolving healthcare landscape.
Regarding the stake size, VinaCapital's Vietnam Opportunity Fund (VOF) initially acquired a significant minority stake in Tam Tri Medical in 2018. Over time, VOF increased its ownership, and by 2024, it held a majority stake in the company.